Integrative Therapies for Veterans’ Mental Health

Interest in alternative and plant-based therapies for veteran mental health has grown as many former service members continue to navigate PTSD, depression, and suicide risk in ways that aren’t always fully addressed by conventional treatments alone. Approaches such as meditation, breathwork, acupuncture, and trauma-informed yoga are increasingly being integrated into veteran care models, often alongside clinical support. In parallel, plant-based therapies—including substances like psilocybin, MDMA-assisted therapy, and traditional plant medicines such as ayahuasca—are being explored in both research and carefully guided retreat settings. The goal is to create more pathways for healing that address the emotional, neurological, and spiritual dimensions of trauma.

Documentaries like Waves and War highlight this shift through personal stories of veterans seeking healing outside traditional systems. The film follows former Navy SEAL Marcus Capone and others as they pursue ibogaine and 5-MeO-DMT treatments in clinical settings abroad, reporting significant reductions in PTSD symptoms, depression, and suicidal ideation. While these experiences are powerful, they also point to a broader movement—one that includes ongoing research from institutions like Johns Hopkins, NYU, and MAPS (Multidisciplinary Association for Psychedelic Studies). Clinical trials have shown promising results, particularly with MDMA-assisted therapy for PTSD, where participants have demonstrated sustained symptom reduction over time. These findings are helping shift public and medical conversations toward a more integrative understanding of trauma recovery.

The legal landscape for plant-based and psychedelic therapies in the U.S. is evolving, but remains a patchwork. Oregon and Colorado have taken the most significant steps, creating regulated programs for supervised psilocybin use, with licensed facilitators and legal service centers. States like California have introduced similar legislation, though efforts have faced delays or partial approvals at the local level. Meanwhile, MDMA-assisted therapy for PTSD is in advanced clinical review with the FDA and may become a prescribable treatment in the near future if approved. In other states, access is largely limited to clinical trials or underground/retreat settings, particularly for substances like ibogaine and ayahuasca, which remain federally restricted. Overall, momentum is building, but most access still exists within tightly controlled research environments or emerging state-specific frameworks.

The Siotha Project remains committed to its mission of offering mental health and wellness support through the integrative arts for veterans, families, and community members. We believe that healing is not one-size-fits-all, and that expanding access to a range of supportive practices—both traditional and emerging—aligns with our mission and vision. We will continue to stay informed on emerging research, legal developments, and accessible resources related to alternative and plant-based therapies, sharing relevant updates to better support the veteran community in making informed, supported decisions around their care.